Eric Dessertenne
Vorstandsvorsitzender bei BIOCORP
Aktive Positionen von Eric Dessertenne
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BIOCORP | Vorstandsvorsitzender | 23.12.2019 | - |
Geschäftsführer | 09.12.2016 | 23.12.2019 | |
Corporate Officer/Principal | 01.06.2014 | 09.12.2016 | |
Groupement foncier agricole René PATOU | Corporate Officer/Principal | - | - |
Aagie Sas | Vorsitzender | - | - |
Karriereverlauf von Eric Dessertenne
Ehemalige bekannte Positionen von Eric Dessertenne
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Brenus Pharma SAS
Brenus Pharma SAS Miscellaneous Commercial ServicesCommercial Services Brenus Pharma SAS is a French company that has developed an allogeneic platform to generate first in class immune therapy to prevent cancer resistance over treatment. The company is based in Issoire, France. The company's technology, stc10-10, targets mss and msi-h population with a robust and validated preclinical data pack to offer an off-the-shelf technology allowing control of both time and cost of the manufacturing process. Brenus Pharma aims to harness a specific, highly potent, and durable immune response against moving targets in cancer by claiming the representativity, the antigenicity, and the immunogenicity of its solution. The company was founded by Benoit Pinteur, Jacques Gardette. The CEO is Paul Bravetti. | Vorstandsvorsitzender | - | - |
Ausbildung von Eric Dessertenne
ESSEC Business School | Masters Business Admin |
Université Blaise Pascal | Undergraduate Degree |
Statistik
International
Frankreich | 7 |
Operativ
Chief Executive Officer | 2 |
Corporate Officer/Principal | 2 |
Chief Operating Officer | 1 |
Sektoral
Consumer Services | 3 |
Health Technology | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BIOCORP | Health Technology |
Private Unternehmen | 3 |
---|---|
Brenus Pharma SAS
Brenus Pharma SAS Miscellaneous Commercial ServicesCommercial Services Brenus Pharma SAS is a French company that has developed an allogeneic platform to generate first in class immune therapy to prevent cancer resistance over treatment. The company is based in Issoire, France. The company's technology, stc10-10, targets mss and msi-h population with a robust and validated preclinical data pack to offer an off-the-shelf technology allowing control of both time and cost of the manufacturing process. Brenus Pharma aims to harness a specific, highly potent, and durable immune response against moving targets in cancer by claiming the representativity, the antigenicity, and the immunogenicity of its solution. The company was founded by Benoit Pinteur, Jacques Gardette. The CEO is Paul Bravetti. | Commercial Services |
Groupement foncier agricole René PATOU | |
Aagie Sas |
- Börse
- Insiders
- Eric Dessertenne
- Erfahrung